arrow
M

Morgane Rolland

Henry M. Jackson Foundation
H指数:43
被引数:7,553

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials

抗体介导预防试验中,使用广谱中和抗体VRC01进行预防性治疗会在感染后选择逃逸突变体

2026-09-280
OA
VRC01 Exerted Differential Pressure on HIV-1 Envelope From Subtypes B and C That Continued in the First Weeks Postdiagnosis in the Antibody Mediated Prevention Trials

VRC01 对 B 和 C 亚型 HIV-1 包膜施加的差异压力在抗体介导的预防试验中确诊后的前几周持续存在

2026-09-080
OAAI
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection

长读长深度测序揭示急性HIV感染中多谱系传播的高速率和病毒群体的快速变化

2026-05-250
OAAI
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

在抗体介导的预防试验中,广泛中和抗体VRC01对HIV突破性病毒人群的影响

2026-04-030
OAAI
Extended in vivo activity of VRC01 HIV-1 prophylaxis entails initial protective efficacy and subsequent breakthrough infections

VRC01 HIV-1预防性治疗的体内持续活性涉及初始保护效果及后续突破性感染

2026-01-010
OA
HIV serologic reactivity varies with time of ART initiation in persons on long-term ART

HIV血清学反应随长期接受ART治疗者ART起始时间的变化而变化

2025-12-010
PRE
Bayesian estimation of HIV acquisition dates for prevention trials

贝叶斯方法估计HIV感染日期用于预防试验

MBIO
IF4.7
2025-09-010
OA
High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa

东非生活于HIV-1亚型A1的女性中,高病毒血症后出现自发性HIV-1控制。

2025-08-100
OAAI
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
2024-09-020
OAAI
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption
2024-06-010
OAAI
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding
2024-05-090
OAAI
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features
2024-03-112
OAAI
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features

广泛中和抗体VRC01的预防功效取决于HIV-1的包膜序列特征

2024-01-194
OAAI
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
2024-01-033
OAAI